Bioenergetics of rat prostate cancer cell migration

Prostate

Volumn 34, Issue 2, 1998, Pages 137-144

  Kouvroukoglou, Stylianos ^a   Lakkis, Clair L ^b   Wallace, John D ^b   Zygourakis, Kyriacos ^a   Epner, Daniel E ^b,c  

^a Rice University   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cell motility; Glycolysis; Videomicroscopy

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIMYCIN A1; GLUCOSE; LACTIC ACID; ROTENONE;

ANIMAL CELL; ARTICLE; BIOENERGY; CELL METABOLISM; CELL MIGRATION; CONTROLLED STUDY; CULTURE MEDIUM; ELECTRON TRANSPORT; GLYCOLYSIS; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROSTATE CANCER; RAT; VELOCITY;

NON-PROGRAMMATIC;

ADENOCARCINOMA; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIMYCIN A; CELL MOVEMENT; CULTURE MEDIA; ELECTRON TRANSPORT; GLYCOLYSIS; LACTATES; MALE; OXYGEN CONSUMPTION; PROSTATIC NEOPLASMS; RATS; ROTENONE; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0031911951     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980201)34:2<137::AID-PROS9>3.0.CO;2-H     Document Type: Article

References (44)

1. Warburg OH: "The Metabolism of Tumors." London: Constable, 1930.
2. Voet D, Voet JG: "Biochemistry," 2nd ed. New York: John Wiley & Sons, Inc., 1995.
3. Racker E: Why do tumor cells have a high aerobic glycolysis? J Cell Physiol 1976;89:697-700.
4. Beckner ME, Stracke ML, Liotta LA, Schiffmann E: Glycolysis as primary energy source in tumor cell chemotaxis. JNCI 1990;82: 1836-1840.
5. Bereiter-Hahn J, Stubig C, Heymann V: Cell cycle-related changes in f-actin distribution are correlated with glycolytic activity. Exp Cell Res 1995;218:551-560.
6. Gibbins JR: Metabolic requirements for epithelial migration as defined by the use of metabolic inhibitors in organ culture. Exp Cell Res 1972,71:329-337.
7. Zetter BR: The cellular basis of site-specific tumor metastasis. N Engl J Med 1990;322:605-612.
8. Liotta LA: Cancer cell invasion and metastasis. Sci Am 1992;266: 54-59.
9. Fidler IJ: Invasion and metastasis. In Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE (eds): "Clinical Oncology." New York: Churchill Livingstone, 1995:55-76.
10. Isaacs JT, Isaacs WB, Feitz WFJ, Scheres J: Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancer. Prostate 1986;9:261-281.
11. Lee Y, McIntire LV, Zygourakis K: Analysis of endothelial cell locomotion: Differential effects of motility and contact inhibition. Biotechnol Bioeng 1994;43:622-634.
12. Stanley PE: Extraction of adenosine triphosphate from microbial and somatic cells. Methods Enzymol 1986;133:14-22.
13. Campbell AK: "Chemiluminescence." Chichester: Ellis Horwood, 1988.
14. Fatt I: "The Polarographic Oxygen Sensor: Its Theory of Operation and Its Application in Biology, Medicine, and Technology." Cleveland: CRC Press, 1976.
15. Nakashima RA, Paggi MG, Pedersen PL: Contributions of glycolysis and oxidative phosphorylation to adenosine 5′-triphosphate production in AS-30D hepatoma cells. Cancer Res 1984;44:5702-5706.
16. Silletti S, Yao JP, Pienta KJ, Raz A: Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells. Int J Cancer 1995; 63:100-105.
17. Borsellino N, Belldegrun A, Bonavida B: Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines. Cancer Res 1995;55:4633-4639.
18. Tanaka A, Miyamoto K, Matsuo H, Matsumoto K, Yoshida H: Human androgen-induced growth factor in prostate and breast cancer cells: Its molecular cloning and growth properties. FEBS Lett 1995;363:226-230.
19. Sehgal I, Powers S, Huntley B, Powis G, Pittelkow M, Maihle NJ: Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer. Proc Natl Acad Sci USA 1994;91:4673-4677.
20. Iwamura M, Abrahamsson PA, Foss KA, Wu G, Cockett AT, Deftos LJ: Parathyroid hormone-related protein: A potential autocrine growth regulator in human prostate cancer cell lines. Urology 1994;43:675-679.
21. Connolly JM, Rose DP: Regulation of DU145 human prostate cancer cell proliferation by insulin-like growth factors and its interaction with the epidermal growth factor autocrine loop. Prostate 1994;24:167-175.
22. Myers RB, Kudlow JE, Grizzle WE: Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia. Mod Pathol 1993;6:733-737.
23. Ching KZ, Ramsey E, Pettigrew N, D'Cunha R, Jason M, Dodd JG: Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mol Cell Biochem 1993;126:151-158.
24. McKeehan WL, Hou J, Adams P, Wang F, Yan GC, Kan M: Heparin-binding fibroblast growth factors and prostate cancer. Adv Exp Med Biol 1993;330:203-213.
25. Connolly JM, Rose DP: Interactions between epidermal growth factor-mediated autocrine regulation and linoleic acid-stimulated growth of a human prostate cancer cell line. Prostate 1992;20:151-158.
26. Tillotson JK, Rose DP: Endogenous secretion of epidermal growth factor peptides stimulates growth of DU145 prostate cancer cells. Cancer Lett 1991;60:109-112.
27. Kim JH, Sherwood ER, Sutkowski DM, Lee C, Kozlowski JM: Inhibition of prostatic tumor cell proliferation by suramin: Alterations in TGF alpha-mediated autocrine growth regulation and cell cycle distribution. J Urol 1991;146:171-176.
28. Stearns ME, Stearns M: Autocrine factors, type IV collagenase secretion and prostatic cancer cell invasion. Cancer Metastasis Rev 1993;12:39-52.
29. Connolly JM, Rose DP: Autocrine regulation of DU145 human prostate cancer cell growth by epidermal growth factor-related polypeptides. Prostate 1991;19:173-180.
30. Lloyd SN, Brown IL, Leake RE: Transforming growth factor-alpha expression in benign and malignant human prostatic disease. Int J Biol Markers 1992;7:27-34.
31. Zuck B, Goepfert C, Nedlin-Chittka A, Sohrt K, Voigt KD, Knabbe C: Regulation of fibroblast growth factor-like protein(s) in the androgen-responsive human prostate carcinoma cell line LNCaP. J Steroid Biochem Mol Biol 1992;41:659-663.
32. Evans CP, Walsh DS, Kohn EC: An autocrine motility factor secreted by the Dunning R-3327 rat prostatic adenocarcinoma cell subtype AT2.1. Int J Cancer 1991;49:109-113.
33. Taylor DJ: Interleukin-1 stimulation of fibroblast glycolysis is accompanied by reduced glucose oxidation in the tricarboxylic acid cycle. Biochem Soc Trans 1990;18:982-983.
34. Constantinidis I, Braunschweiger PG, Wehrle JP, Kumar N, Johnson CS, Furmanski P, Glickson JD: 31P-nuclear magnetic resonance studies of the effect of recombinant human interleukin 1 alpha on the bioenergetics of RIF-1 tumors. Cancer Res 1989;49:6379-6382.
35. Resnick RJ, Feldman R, Willard J, Racker E: Effect of growth factors and methionine on glycolysis and methionine transport in rat fibroblasts and fibroblasts transfected with myc and ras genes. Cancer Res 1986;46:1800-1804.
36. Racker E, Riegler C, Abdel-Ghany M: Stimulation of glycolysis by placental polypeptides and inhibition by duramycin. Cancer Res 1984;44:1364-1367.
37. Yu N, Maciejewski-Lenoir D, Bloom FE, Magistretti PJ: Tumor necrosis factor-alpha and interleukin-1 alpha enhance glucose utilization by astrocytes: Involvement of phospholipase A2. Mol Pharmacol 1995;48:550-558.
38. Camacho M, Godessart N, Anton R, Garcia M, Vila L: Interleukin-1 enhances the ability of cultured human umbilical vein endothelial cells to oxidize linoleic acid. J Biol Chem 1995;270: 17279-17286.
39. Frim DM, Simpson J, Uhler TA, Short MP, Bossi SR, Breakefield XO, Isacson O: Striatal degeneration induced by mitochondrial blockade is prevented by biologically delivered NGF. J Neurosci Res 1993;35:452-458.
40. Hue L, Rousseau GG: Fructose 2,6-bisphosphate and the control of glycolysis by growth factors, tumor promoters and oncogenes. Adv Enzyme Regul 1993;33:97-110.
41. Schulze-Osthoff K, Beyaert R, Vandevoorde V, Haegeman G, Fiers W: Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J 1993;12:3095-3104.
42. Baulida J, Onetti R, Bassols A: Effects of epidermal growth factor on glycolysis in A431 cells. Biochem Biophys Res Commun 1992;183:1216-1223.
43. Rago R, Mitchen J, Cheng AL, Oberley T, Wilding G: Disruption of cellular energy balance by suramin in intact human prostatic carcinoma cells, a likely antiproliferative mechanism. Cancer Res 1991;51:6629-6635.
44. Klausmann M, Pfluger KH, Krumwieh D, Seiler FR, Havemann K: Stimulation of oxidative metabolism of granulocytes by recombinant granulocyte-macrophage-colony-stimulating-factor and a conditioned medium of a urinary bladder carcinoma cell line. Blut 1987;54:307-312.